While the FDA may consider an emergency use authorization, a coronavirus vaccine likely won’t be accessible to the general public until next year, says Healthcare Policy Analyst Chris Meekins.
Recorded June 24, 2020.
Markets & Investing Members of the Raymond James Investment Strategy Committee share their views on...
Markets & Investing Review the latest Weekly Headings by CIO Larry Adam. Key Takeaways ...
Technology & Innovation Learn about a few simple things you can do to protect your personal information...